Vyepti is the first anti-CGRP drug to be administered in a quarterly intravenous infusion. Other drugs in this category – Aimovig, Emgality, and Ajovy – are given monthly via injection.
For more information: migraineagain.com/new-vyept...
Vyepti is the first anti-CGRP drug to be administered in a quarterly intravenous infusion. Other drugs in this category – Aimovig, Emgality, and Ajovy – are given monthly via injection.
For more information: migraineagain.com/new-vyept...
Thank you for the link, I have forwarded to my daughter, Blessings Jimeka 🤗
Yes thank you for the info but unless you are covered by private insurance this will not be affordable sadly to a lot of people 🙈 I actually participated in the trials 2014 for Botox and was refused by my doctor even though I take Chronic migraines which I live with daily so not much chance of getting any of this 🙈